# Chipiron

> Chipiron is a Paris-based medical-imaging startup building a compact, low-cost MRI scanner that runs at an ultra-low magnetic field (below ~30 millitesla, roughly 1,000x weaker than a hospital MRI). Its patented low-Tc SQUID quantum detection system plus AI noise cancellation and reconstruction are designed to recover clinical-grade image quality without a shielded room, without helium, and at a fraction of the cost, size, and infrastructure of conventional machines. The company's stated aim is to make MRI accessible everywhere, starting with breast imaging, and eventually reach patients, clinics, and remote settings that today's scanners can't serve.

- **Founded:** 2020
- **Headquarters:** Paris, France
- **Founders:** Evan Kervella (Co-founder & CEO), Dimitri Labat (Co-founder & CSO)
- **Team size:** ~52 employees (per aggregated data; company is a growing deeptech team)
- **Products:** Ultra-low-field portable MRI scanner, Low-Tc SQUID volume gradiometer, AI noise cancellation & low-field reconstruction
- **Notable:** Raised a $17M Series A in 2025, surpassing $22M in total funding since founding., Developed a patented low-Tc SQUID volume gradiometer described as the first SQUID antenna to capture MRI signals in an open environment., Reported up to 10x improvement in signal-to-noise ratio versus room-temperature detection.

## Products & services

- **Ultra-low-field portable MRI scanner** — A compact MRI operating below roughly 30 mT (about 1,000x weaker than conventional hospital MRIs), designed to work without a shielded room and without liquid helium, at a fraction of the cost and footprint.
- **Low-Tc SQUID volume gradiometer** — A patented Superconducting QUantum Interference Device detection system - described as the first SQUID antenna to capture MRI signals in an open environment - improving signal-to-noise ratio by up to 10x versus room-temperature detection.
- **AI noise cancellation & low-field reconstruction** — Linear and non-linear active noise-cancellation strategies plus AI reconstruction tuned for low-field signals, including a breast-dedicated sequence that reduces the number of acquisition repetitions.

## Achievements

- Raised a $17M Series A in 2025, surpassing $22M in total funding since founding.
- Developed a patented low-Tc SQUID volume gradiometer described as the first SQUID antenna to capture MRI signals in an open environment.
- Reported up to 10x improvement in signal-to-noise ratio versus room-temperature detection.
- Backed by a mix of venture (Blast) and major public programs (EIC, France 2030, Bpifrance).

## Latest updates

- **2025-05** — Announced a $17M Series A led by Blast, with the EIC Fund and iXcore, plus public support from France 2030, the EIC Accelerator and Bpifrance; total funding passes $22M.
- **2026** — Plans to build a hospital prototype and begin clinical trials, with a stated goal of ~100 deployed devices within five years and eventual FDA/CE authorization.

## Links

- Website: https://www.chipiron.co
- LinkedIn: https://www.linkedin.com/company/chipiron
- Twitter/X: https://twitter.com/chipiron_mri

---

Profile page: https://yespress.io/chipiron
Published by YesPress — https://yespress.io
Last updated: 2026-07-13